NCT00103662 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 148
- group Id
- BG001
- value
- 154
- group Id
- BG002
- value
- 302
- units
- Participants
- groups
- description
- Participants underwent mobilization with G-CSF for 4 days. On the evening of Day 4, participants received a dose of plerixafor. On each subsequent day, participants received a morning dose of G-CSF followed by apheresis and an evening dose of plerixafor for a maximum of 4 aphereses or until ≥ 6\*10\^6 CD34+ cells/kg were collected.
- id
- BG000
- title
- G-CSF Plus Plerixafor
- description
- Participants underwent mobilization with G-CSF for 4 days. On the evening of Day 4, participants received a dose of placebo. On each subsequent day, participants received a morning dose of G-CSF followed by apheresis and an evening dose of placebo for a maximum of 4 aphereses or until ≥ 6\*10\^6 CD34+ cells/kg were collected.
- id
- BG001
- title
- G-CSF Plus Placebo
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.4
- value
- 58.2
- group Id
- BG001
- spread
- 8.6
- value
- 58.4
- group Id
- BG002
- spread
- 8.5
- value
- 58.3
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 48
- group Id
- BG001
- value
- 47
- group Id
- BG002
- value
- 95
- title
- Female
- measurements
- group Id
- BG000
- value
- 100
- group Id
- BG001
- value
- 107
- group Id
- BG002
- value
- 207
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 117
- group Id
- BG001
- value
- 128
- group Id
- BG002
- value
- 245
- title
- Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 32
- title
- African-American
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 15
- title
- Hispanic/Latino
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 6
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 148
- group Id
- BG001
- value
- 154
- group Id
- BG002
- value
- 302
- units
- Participants
- groups
- description
- Participants underwent mobilization with G-CSF for 4 days. On the evening of Day 4, participants received a dose of plerixafor. On each subsequent day, participants received a morning dose of G-CSF followed by apheresis and an evening dose of plerixafor for a maximum of 4 aphereses or until ≥ 6\*10\^6 CD34+ cells/kg were collected.
- id
- BG000
- title
- G-CSF Plus Plerixafor
- description
- Participants underwent mobilization with G-CSF for 4 days. On the evening of Day 4, participants received a dose of placebo. On each subsequent day, participants received a morning dose of G-CSF followed by apheresis and an evening dose of placebo for a maximum of 4 aphereses or until ≥ 6\*10\^6 CD34+ cells/kg were collected.
- id
- BG001
- title
- G-CSF Plus Placebo
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.4
- value
- 58.2
- group Id
- BG001
- spread
- 8.6
- value
- 58.4
- group Id
- BG002
- spread
- 8.5
- value
- 58.3
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 48
- group Id
- BG001
- value
- 47
- group Id
- BG002
- value
- 95
- title
- Female
- measurements
- group Id
- BG000
- value
- 100
- group Id
- BG001
- value
- 107
- group Id
- BG002
- value
- 207
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 117
- group Id
- BG001
- value
- 128
- group Id
- BG002
- value
- 245
- title
- Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 32
- title
- African-American
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 15
- title
- Hispanic/Latino
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 6
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle